Researchers from Charité – Universitätsmedizin Berlin and the Zuse Institute Berlin have developed a new generation of pain medications.
The researchers used computer simulations to develop new opioids that will only work at sites affected by injury or inflammation. These drugs can prevent the occurrence of brain- and gut-related side effects typically associated with conventional opioids and have been shown to be successful in preclinical studies. Results from this research have been published in Pain* and Scientific Reports**.
Opioids are a class of drugs with powerful pain-relieving properties. They are mainly used to treat the pain associated with tissue damage and inflammation, such as that caused by surgery or cancer. Common side effects associated with their use include drowsiness, nausea, constipation, dependency and, in some cases, respiratory arrest. The research team, which is led by Prof. Dr. Christoph Stein of the Department of Anesthesiology and Surgical Intensive Care Medicine on Campus Benjamin Franklin, are hoping to develop new types of pain medications which will work without producing dangerous side effects. Collaborating with PD Dr. Marcus Weber of the Zuse Institute Berlin, the researchers used computer simulations to develop two new opioids. In both cases, the researchers used fentanyl as the starting molecule.
The researchers hypothesized that tissues which are damaged or inflamed show stronger interaction between ‘opioid agonists’ – the substances that elicit the pain-relieving effect – and the opioid receptors they bind to. Their computer simulations suggested that this is due to an increased concentration of protons in inflamed tissues, which leads to lower pH values than in healthy tissues, resulting in acidic conditions. Opioid molecules need to undergo protonation before they can bind to and activate opioid receptors. The researchers used this knowledge to design two drugs that would only exist in their protonated state in the presence of inflammation. This restricts opioid receptor activation to sites of tissue damage or inflammation, rather than receptors in the brain or gut.
“Our innovative design method provides a robust basis for a new generation of pain medications,” reports Prof. Stein. He adds: “These drugs could help us both to avoid the dangerous side effects of conventional opioids and to reduce complications. They would also help us stem the opioid crisis, a problem that is particularly evident in the United States.”
The researchers hope to further develop these newly-designed drugs in order to make them available to patients. They also plan to enhance their understanding of the molecular processes underlying the complex interactions seen in inflamed tissues, in the hope that they may be able to support opioid optimization through the insights they gain. Ideally, their insights will also be beneficial for other drugs, such as those used to treat high blood pressure.
The Latest on: Pain medications
via Google News
The Latest on: Pain medications
- ‘We still have an epidemic; there are just different drugs involved’: Opioid deaths rose as prescriptions fellon November 17, 2019 at 7:00 am
He needed two elbow surgeries, and doctors prescribed him painkillers to deal with the pain. His last surgery was when he was 18. Before he knew it, his parents said, Tyler was addicted to opioids.
- Heart disease patients with chest pain may not need a stenton November 17, 2019 at 6:00 am
For people with heart disease, it’s been thought that inserting a stent was the best way to treat sudden chest pain during exercise. But a landmark study suggests that this invasive procedure might ...
- Dry needling offers alternative to pain medicationson November 16, 2019 at 10:10 pm
Dry needling employs a Western philosophy of attacking pain trigger points, the bands of tight fascia or muscle commonly known as knots. Originally, anesthesia was injected through hypodermic needles.
- For Heart Disease, Medications May Work As Well As Invasive Surgery, Major Trial Showson November 16, 2019 at 4:55 pm
hospitalization for unstable chest pain or heart failure, resuscitation after cardiac arrest and death from cardiovascular causes. “Patients want to know, is this treatment going to make me live ...
- New Study Shows Heart Medications May Be Just As Effective If Not Better Than Procedureson November 16, 2019 at 1:36 pm
About 17 million Americans have clogged arteries that crimp the heart's blood supply, which can cause periodic chest pain. Cheap and generic aspirin, cholesterol-lowering drugs and blood pressure ...
- Column: Medicare can help manage pain with therapy, medicationon November 16, 2019 at 2:12 am
Mahalo for reading the Honolulu Star-Advertiser! You're reading a premium story. Read the full story with our Print & Digital Subscription.
- Regular use of prescription drugs for pain and sleep increases frailty risk by 95 percenton November 14, 2019 at 12:45 am
Researchers from the Oregon Research Institute (ORI) and Florida Atlantic University (FAU) are the first to demonstrate statistically significant links between self-reported regular use of ...
- Bone Pain Treatment Market Highlights Key Development Factors and Upcoming Trends During forecast 2019-2026on November 13, 2019 at 6:06 pm
Nov 13, 2019 (Global QYResearch via COMTEX) -- Ameco Research added new research report to its vast database titled "Global Bone Pain Treatment Market 2019" which provides extensive and highly ...
- Black, Hispanic mothers report more pain after delivery but get less pain medicationon November 12, 2019 at 2:01 pm
(Reuters Health) - White mothers may receive more pain assessments after delivery and have better access to painkillers than women from other racial and ethnic groups, two new studies suggest. For one ...
via Bing News